Search Results for "Wockhardt Europe Ltd"

04:23 EDT 28th October 2016 | BioPortfolio

Matching Channels


The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...


Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...


AA amyloidosis affects approximately 35,000 - 50,000 individuals in the United States, Europe (Top 5 countries) and Japan. The disease occurs in a subset of patients with long-lasting inflammatory c...


At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Phoenix MarCom

Phoenix MarCom is a specialist marketing communications company, working with clients in the clean tech (including renewables, environmental technology, low carbon and sustainability), scientific an...

Matching News

Third strike for Wockhardt as API facility hit with US import alert

The US FDA has banned products from a third Indian manufacturing plant operated by Wockhardt.

Wockhardt consolidated net dips by 83% in Q1 to Rs. 16 cr

Wockhardt, a Rs. 4,450 crore plus pharma major, has suffered heavy setback during the first quarter ended June 2016 and its consolidated net profit declined sharply by 82.7 per cent to Rs. 15.89 crore...

Novartis Galvus India Case: Wockhardt Pulls Back?

Legal proceedings around Novartis' Galvus patent in India appear to have taken an interesting turn, with generic challenger Wockhardt indicating...  

U.S. FDA Grants QIDP Status for Wockhardt Anti-Infective Drug Discovery Program

PARSIPPANY, N.J., Aug. 31, 2014 /PRNewswire/ -- Wockhardt Limited today announces a major boost to the New Drug Discovery program in Anti-Infective research when two of its drugs, WCK 771 and WCK 2349...

Global drugmakers pledge to fight against antimicrobial resistance

Biospectrum Thirteen major drugmakers including Cipla and Wockhardt from India have teamed up in laying out a roadmap t...

Going big in Europe

Ebb & Flow Going big in Europe Arch Venture's biggest investment to date in Europe is also the complete opposite of how the firm normally starts biotech companies. Arch is co-leading a tranched $95 mi...

FDA's NDA And BLA Approvals:

Below are FDA's original approvals of NDAs and BLAs issued in the past week. Please see key below chart for...   

Chemspec Europe 2016 ends with positive results

Chemspec Europe 2016 received excellent evaluations from exhibitors, visitors and conference delegates alike, from inside and outside of Europe

Matching PubMed Articles

Longitudinal Predictors of Functional Impairment in Older Adults in Europe - Evidence from the Survey of Health, Ageing and Retirement in Europe.

To examine time-dependent predictors of functional impairment in older adults in Europe longitudinally.

The genetic history of Ice Age Europe.

Modern humans arrived in Europe ~45,000 years ago, but little is known about their genetic composition before the start of farming ~8,500 years ago. Here we analyse genome-wide data from 51 Eurasians ...

Dirofilaria repens Microfilaremia in Three Dogs in Estonia.

In Europe, the zoonotic parasite Dirofilaria repens continues to spread northward. We describe three likely autochthonous canine microfilaremic D. repens infections from Estonia, an European Union cou...

Dengue and other Aedes-borne viruses: a threat to Europe?

Corrigendum to "EuReCa ONE-27 Nations, ONE Europe, ONE Registry A prospective one month analysis of out-of-hospital cardiac arrest outcomes in 27 countries in Europe" Resuscitation 105 (2016) 188-195.

Search Whole site using Google

Quick Search
Advertisement Advertisement